Renal Stone Disease and Obesity: What is Important for Urologists and Nephrologists?

REFERENCES

• Monk RD. Clinical approach to adults. Semin Nephrol. 1996;16:375–388.
   PubMed Web of Science ®Google Scholar
• Buchholz NP, Abbas F, Afzal M, Khan R, Rizvi I, Talati J. The prevalence of silent kidney stones – an ultrasonographic screening study. J Pak Med Assoc. 2003;53:24–25.
   PubMedGoogle Scholar
• Indridason OS, Birgisson S, Edvardsson VO, Sigvaldason H, Sigfusson N, Palsson R. Epidemiology of kidney stones in Iceland: a population-based study. Scand J Urol Nephrol. 2006;40:215–220.
   PubMed Web of Science ®Google Scholar
• Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–899.
   PubMed Web of Science ®Google Scholar
• Hootan TM. Urinary tract infection in adults. In: Johnson RJ, Feehally J, eds. Comprehensive Clinical Nephrology. 2nd ed. London: Mosby; 2003:731–744.
   Google Scholar
• Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br J Urol. 1984;56:122–124.
   PubMedGoogle Scholar
• Shekarriz B, Stoller ML. Uric acid nephrolithiasis: current concepts and controversies. J Urol. 2002;168:1307–1314.
   PubMed Web of Science ®Google Scholar
• McPhail EF, Gettman MT, Patterson DE, Rangel LJ, Krambeck AE. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. Urology. 2012;79:277–281.
   PubMed Web of Science ®Google Scholar
• Goldfarb DS, Coe FL. Prevention of recurrent nephrolithiasis. Am Fam Physician. 1999;60:2269–2276.
   PubMed Web of Science ®Google Scholar
• Domingos F, Serra A. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant. 2011;26:864–868.
   PubMed Web of Science ®Google Scholar
• Rule AD, Roger VL, Melton LJ III, . Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21:1641–1644.
   PubMed Web of Science ®Google Scholar
• Saucier NA, Sinha MK, Liang KV, . Risk factors for CKD in persons with kidney stones: a case–control study in Olmsted County, Minnesota. Am J Kidney Dis. 2010;55:61–68.
   PubMed Web of Science ®Google Scholar
• Brener ZZ, Winchester JF, Salman H, Bergman M. Nephrolithiasis: evaluation and management. South Med J. 2011;104:133–139.
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Byrne CD. Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrol Dial Transplant. 2010;25:3142–3147.
   PubMed Web of Science ®Google Scholar
• Ahmed MH. Orlistat and calcium oxalate crystalluria: an association that needs consideration. Ren Fail. 2010;32:1019–1021.
   PubMed Web of Science ®Google Scholar
• Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4:1565–1574.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Cleary MP, O’Donnell MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med. 1985;106:598–604.
   PubMed Web of Science ®Google Scholar
• Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol. 2001;12:1211–1217.
   PubMed Web of Science ®Google Scholar
• Mathew AV, Okada S, Sharma K. Obesity related kidney disease. Curr Diabetes Rev. 2011;7:41–49.
   PubMedGoogle Scholar
• Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–1509.
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Byrne CD. Metabolic syndrome, diabetes & CHD risk. In: Packard CJ, ed. The Year in Lipid Disorders. Oxford: Clinical Publishing;2007:3–26.
   Google Scholar
• Ahmed MH, Khalil A, Osman MM. Nitric oxide as treatment for an emerging epidemic of obesity-related glomerulopathy. Diabetes Res Clin Pract. 2006;74:207–208.
   PubMed Web of Science ®Google Scholar
• Wesson DE, Kurtzman NA, Frommer JP. Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron. 1985;40:235–237.
   PubMed Web of Science ®Google Scholar
• Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R, Matlaga BR. The Association of increasing body mass index and kidney stone disease. J Urol. 2010;183:571–575.
   PubMed Web of Science ®Google Scholar
• Ahmed MH, Byrne CD. Current treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab. 2009;11:188–195.
   PubMed Web of Science ®Google Scholar
• Khan SR. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res. 2012;40:95–112.
   PubMedGoogle Scholar
• Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008;21:257–264.
   PubMed Web of Science ®Google Scholar
• Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res. 2008;36:303–307.
   PubMedGoogle Scholar
• Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. J Am Med Assoc. 2005;293:455–462.
   PubMed Web of Science ®Google Scholar
• Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol. 2008;179:570–574.
   PubMed Web of Science ®Google Scholar
• Nowfar S, Palazzi-Churas K, Chang DC, Sur RL. The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis. Urology. 2011;78:1029–1033.
   PubMed Web of Science ®Google Scholar
• Strope SA, Wolf JS Jr, Hollenbeck BK. Changes in gender distribution of urinary stone disease. Urology. 2010;75:543–546.
   PubMed Web of Science ®Google Scholar
• Scales CD Jr, Curtis LH, Norris RD, . Changing gender prevalence of stone disease. J Urol. 2007;177:979–982.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–838.
   PubMed Web of Science ®Google Scholar
• Kaul P, Sidhu H, Sharma SK, Nath R. Calculogenic potential of galactose and fructose in relation to urinary excretion of lithogenic substances in vitamin B6 deficient and control rats. J Am Coll Nutr. 1996;15:295–302.
   PubMed Web of Science ®Google Scholar
• Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65:1422–1425.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–915.
   PubMed Web of Science ®Google Scholar
• Asplin JR. Obesity and urolithiasis. Adv Chronic Kidney Dis. 2009;16:11–20.
   PubMed Web of Science ®Google Scholar
• Cignarelli M, Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis. 2007;17:757–762.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: The National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008; 51:741–747.
   PubMed Web of Science ®Google Scholar
• Jeong IG, Kang T, Bang JK, . Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis. 2011;58:383–388.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Kohjimoto Y, Iba A, Saji F, Hara I, Shigematsu T. Calcium oxalate crystal deposition in metabolic syndrome model rat kidneys. Int J Urol. 2010;17:996–1003.
   PubMed Web of Science ®Google Scholar
• Afsar B, Yilmaz M, Eyileten T. Do patients with uric acid stones exhibit abnormal circadian blood pressure – a hypothesis. Nephrol Dial Transplant. 2009;24:2004–2005.
   PubMed Web of Science ®Google Scholar
• Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007;2:883–888.
   PubMed Web of Science ®Google Scholar
• Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386–392.
   PubMed Web of Science ®Google Scholar
• Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002;62:971–979.
   PubMed Web of Science ®Google Scholar
• Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–1235.
   PubMed Web of Science ®Google Scholar
• Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010;183:2244–2248.
   PubMed Web of Science ®Google Scholar
• Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant. 2005;20:468–469.
   PubMed Web of Science ®Google Scholar
• Daudon M, Traxer O, Conort P, Lacour B, Jungers JP.Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol. 2006;17:2026–2033.
   PubMed Web of Science ®Google Scholar
• Vollans SR, Sehjal R, Forster JA, Rogawski KM. Emphysematous pyelonephritis in type II diabetes: a case report of an undiagnosed ureteric colic. Cases J. 2008;1:192.
   PubMedGoogle Scholar
• Chan AC, Rohan MJ, Hamid A, Azam A. Emphysematous pyelonephritis in a diabetic patient with pelvic-ureteric stone. Med J Malaysia. 2007;62:166–167.
   PubMedGoogle Scholar
• Chung SD, Liao CH, Sun HD, Wen WC. Emphysematous pyelonephritis with acute renal failure. Urology. 2008;72:521–522.
   PubMed Web of Science ®Google Scholar
• Serrano PE, Khuder SA, Fath JJ. Obesity as a risk factor for nosocomial infections in trauma patients. J Am Coll Surg. 2010;211:61–67.
   PubMed Web of Science ®Google Scholar
• Bochicchio GV, Joshi M, Shih D, Bochicchio K, Tracy K, Scalea TM. Reclassification of urinary tract infections in critically ill trauma patients: a time-dependent analysis. Surg Infect (Larchmt). 2003;4:379–385.
   PubMedGoogle Scholar
• Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR. The impact of obesity on urinary tract infection risk. Urology. 2012;79:266–269.
   PubMed Web of Science ®Google Scholar
• Haidinger G, Temml C, Schatzl G, . Risk factors for lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology. Eur Urol. 2000;37:413–420.
   PubMed Web of Science ®Google Scholar
• Aboumarzouk OM, Somani B, Monga M. Safety and efficacy of ureteroscopic lithotripsy for stone disease in obese patients: a systematic review of the literature. BJU Int. 2012. doi: 10.1111/j.1464-410X.2012.11086.x. [Epub ahead of print].
   Google Scholar
• El-Assmy AM, Shokeir AA, El-Nahas AR, . Outcome of percutaneous nephrolithotomy: effect of body mass index. Eur Urol. 2007;52:199–204.
   PubMed Web of Science ®Google Scholar
• Duvdevani M, Nott L, Ray AA, Ko R, Denstedt JD, Razvi H. Percutaneous nephrolithotripsy in patients with diabetes mellitus. J Endourol. 2009;23:21–26.
   PubMed Web of Science ®Google Scholar
• Krambeck AE, Gettman MT, Rohlinger AL, Lohse CM, Patterson DE, Segura JW. Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol. 2006;175:1742–1747.
   PubMed Web of Science ®Google Scholar
• de CM, Krambeck AE, Rule AD, . Shock wave lithotripsy and diabetes mellitus: a population-based cohort study. Urology. 2012;79:298–302.
   PubMed Web of Science ®Google Scholar
• Sato Y, Tanda H, Kato S, . Shock wave lithotripsy for renal stones is not associated with hypertension and diabetes mellitus. Urology. 2008;71:586–591.
   PubMed Web of Science ®Google Scholar